About this Course
This course is a recorded (home study version) of the CE Finale Encore Webinars.
Upon completion of this application based CE Activity, a pharmacist will be able to:
|· Explain how the immune system responds to a booster dose of a vaccine|
|· Concisely explain the clinical outcome data supporting administration of COVID-19 3rd doses and/or booster doses|
|· Given a specific patient case, determine whether they would qualify for a COVID-19 vaccine booster dose and recommend an appropriate product to administer.|
Release and Expiration Dates
Released: December 20, 2021
Expires: December 17, 2024
1.0 hours of CE
|The University of Connecticut School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.|
Pharmacists and Pharmacy Technicians are eligible to participate in this application-based activity and will receive up to 1.0 CE Hours (or 0.1 CEUs) for completing the activity ACPE UAN 0009-0000-21-057-H06-P, passing the quiz with a grade of 70% or better, and completing an online evaluation. Statements of credit are available via the CPE Monitor online system and your participation will be recorded with CPE Monitor within 72 hours of submission.
Jeffery Aeschlimann, PharmD
Associate Clinical Professor-Infectious Disease Specialty
University of Connecticut School of Pharmacy
In accordance with the Accreditation Council for Pharmacy Education (ACPE) Criteria for Quality and Interpretive Guidelines, The University of Connecticut School of Pharmacy requires that faculty disclose any relationship that the faculty may have with commercial entities whose products or services may be mentioned in the activity.
- Jeffery Aeschlimann has no relationships with ineligible companies
The material presented here does not necessarily reflect the views of The University of Connecticut School of Pharmacy or its co-sponsor affiliates. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.